Search results
Found 30060 matches for
A new study by researchers at NDORMS, University of Oxford now published in Osteoarthritis and Cartilage found that the average lifetime risk of needing further surgery following knee and hip replacement – revision surgery – was around 5% after knee replacement and 8% after hip replacement, with neither body mass index (BMI, combining an individual's height and weight) or smoking having any meaningful effect on these risks.
Botnar Institute Student Symposium 2025
Wednesday, 11 June 2025
BISS is back! Join us for a day of presentations, posters, activities and quizzes to celebrate our brilliant Botnar students.
Trials Expertise Session: The role of a Trial Manager in a Trial Management Group (TMG) *online*
Thursday, 12 June 2025, 10am to 11am
Trials Expertise Session: Communication skills in Clinical Trials for Trial Managers *online*
Wednesday, 26 March 2025, 10am to 11am
Trials Expertise Session: Site Feasibility Questionnaires (SFQ) & Site selection *Hybrid*
Wednesday, 21 May 2025, 2pm to 3pm
Meet the team
-
Ed Burn
Senior Researcher in Epidemiology and Health Economics
-
Daniel Prieto-Alhambra
Professor of Pharmaco- and Device Epidemiology
-
Rafael Pinedo Villanueva
Associate Professor
-
David Murray
Professor of Orthopaedic Surgery
-
Cyrus Cooper
Professor of Musculoskeletal Science, University of Oxford
Funder
Read the paper
The impact of bmi and smoking on risk of revision following knee and hip replacement surgery: evidence from routinely collected data
Osteoarthritis and Cartilage, May 2019